AAAAAA
Results:
1-17
|
Results: 17
Authors:
Suou, T
Mitsuda, A
Koda, M
Matsuda, H
Maruyama, S
Tanaka, H
Kishimoto, Y
Michimori, K
Hirooka, Y
Kawasaki, H
Citation: T. Suou et al., Interferon alpha inhibits intrahepatic recurrence in hepatocellular carcinoma with chronic hepatitis C: a pilot study, HEPATOL RES, 20(3), 2001, pp. 301-311
Authors:
Kishimoto, Y
Morisawa, T
Kitano, M
Shiota, G
Horie, Y
Suou, T
Ito, H
Kawasaki, H
Hasegawa, J
Citation: Y. Kishimoto et al., Loss of heterozygosity of the mannose 6-phosphate/insulin-like growth factor II receptor and p53 genes in human hepatocellular carcinoma, HEPATOL RES, 20(1), 2001, pp. 68-83
Authors:
Ishiga, K
Kawatani, T
Suou, T
Tajima, F
Omura, H
Idobe, Y
Kawasaki, H
Citation: K. Ishiga et al., Fulminant hepatitis type B after chemotherapy in a serologically negative hepatitis B virus carrier with acute myelogenous leukemia, INT J HEMAT, 73(1), 2001, pp. 115-118
Authors:
Kawatani, T
Suou, T
Tajima, F
Ishiga, K
Omura, H
Endo, A
Ohmura, H
Ikuta, Y
Idobe, Y
Kawasaki, H
Citation: T. Kawatani et al., Incidence of hepatitis virus infection and severe liver dysfunction in patients receiving chemotherapy for hematologic malignancies, EUR J HAEMA, 67(1), 2001, pp. 45-50
Authors:
Kase, S
Shiota, G
Fujii, Y
Okamoto, K
Oyama, K
Nakano, T
Nomura, T
Suou, T
Nakashima, K
Ito, H
Kawasaki, H
Citation: S. Kase et al., Inclusion body myositis associated with hepatitis C virus infection, LIVER, 21(5), 2001, pp. 357-360
Authors:
Koda, M
Murawaki, Y
Mitsuda, A
Oyama, K
Okamoto, K
Idobe, Y
Suou, T
Kawasaki, H
Citation: M. Koda et al., Combination therapy with transcatheter arterial chemoembolization and percutaneous ethanol injection compared with percutaneous ethanol injection alone for patients with small hepatocellular carcinoma - A randomized control study, CANCER, 92(6), 2001, pp. 1516-1524
Authors:
Koda, M
Tanaka, H
Murawaki, Y
Horie, Y
Suou, T
Kawasaki, H
Ikawa, S
Citation: M. Koda et al., Liver perforation: A serious complication of percutaneous acetic acid injection for hepatocellular carcinoma, HEP-GASTRO, 47(34), 2000, pp. 1110-1112
Authors:
Mitsuda, A
Suou, T
Ikuta, Y
Kawasaki, H
Citation: A. Mitsuda et al., Changes in serum tissue inhibitor of matrix metalloproteinase-1 after interferon alpha treatment in chronic hepatitis C, J HEPATOL, 32(4), 2000, pp. 666-672
Authors:
Shiota, G
Ishida, M
Noguchi, N
Oyama, K
Takano, Y
Okubo, M
Katayama, S
Tomie, Y
Harada, K
Hori, K
Ashida, K
Kishimoto, Y
Hosoda, A
Suou, T
Kanbe, T
Tanaka, K
Nosaka, K
Tanida, O
Kojo, H
Miura, K
Ito, H
Kaibara, N
Kawasaki, H
Citation: G. Shiota et al., Circulating p53 antibody in patients with colorectal cancer - Relation to clinicopathologic features and survival, DIG DIS SCI, 45(1), 2000, pp. 122-128
Authors:
Shiota, G
Oyama, K
Udagawa, A
Tanaka, K
Nomi, T
Kitamura, A
Tsutsumi, A
Noguchi, N
Takano, Y
Yashima, K
Kishimoto, Y
Suou, T
Kawasaki, H
Citation: G. Shiota et al., Occult hepatitis B virus infection in HBs antigen-negative hepatocellular carcinoma in a Japanese population: Involvement of HBx and p53, J MED VIROL, 62(2), 2000, pp. 151-158
Authors:
Shiota, G
Harada, K
Oyama, K
Udagawa, A
Nomi, T
Tanaka, K
Tsutsumi, A
Noguchi, N
Kishimoto, Y
Horie, Y
Suou, T
Kawasaki, H
Citation: G. Shiota et al., Severe exacerbation of hepatitis after short-term corticosteroid therapy in a patient with "latent" chronic hepatitis B, LIVER, 20(5), 2000, pp. 415-420
Authors:
Koda, M
Murawaki, Y
Mitsuda, A
Ohyama, K
Horie, Y
Suou, T
Kawasaki, H
Ikawa, S
Citation: M. Koda et al., Predictive factors for intrahepatic recurrence after percutaneous ethanol injection therapy for small hepatocellular carcinoma, CANCER, 88(3), 2000, pp. 529-537
Authors:
Maeda, N
Tanaka, S
Andachi, H
Osaki, M
Horie, Y
Suou, T
Kawasaki, H
Citation: N. Maeda et al., Solitary hepatic tuberculoma with chronic hepatitis C diagnosed by polymerase chain reaction using paraffin-embedded resected specimen, HEPATOL RES, 15(1), 1999, pp. 80-89
Authors:
Yamada, S
Suou, T
Kawasaki, H
Horie, Y
Nagami, M
Yashima, S
Sugihara, C
Tanaka, H
Citation: S. Yamada et al., Changes of hepatic vitronectin levels in patients with chronic hepatitis Ctreated with interferon alpha, RES COM M P, 104(3), 1999, pp. 253-263
Authors:
Suou, T
Citation: T. Suou, Antifibrogenic activity of interferon alpha in chronic hepatitis C, J GASTRO, 34(3), 1999, pp. 426-427
Authors:
Koda, M
Murawaki, Y
Idobe, Y
Horie, Y
Suou, T
Kawasaki, H
Ikawa, S
Citation: M. Koda et al., Is choledocholithiasis a late complication of nonresectional therapies forhepatocellular carcinoma?, HEP-GASTRO, 46(30), 1999, pp. 3091-3094
Authors:
Horie, Y
Shigoku, A
Tanaka, H
Tomie, Y
Maeda, N
Hoshino, U
Koda, M
Shiota, G
Yamamoto, T
Kato, S
Murawaki, Y
Suou, T
Kawasaki, H
Citation: Y. Horie et al., Prognosis for pedunculated hepatocellular carcinoma, ONCOL-BASEL, 57(1), 1999, pp. 23-28
Risultati:
1-17
|